| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 2,500 | $10.01 | $25,025.00 | -0.7% | |
| Jan 9, 2020 | Quimi Daphne58 | Chief Financial Officer | Sale+OE | 15,000 | $9.93 | $148,951.50 | -8.2% | |
| Jan 9, 2020 | McGlynn Margaret G51 | Director | Sale+OE | 20,000 | $10.00 | $200,000.00 | -47.5% | |
| Jan 7, 2020 | Barth Jay | Chief Medical Officer | Sell | 16,774 | $9.32 | $156,394.77 | -4.9% | |
| Jan 2, 2020 | Barth Jay | Chief Medical Officer | Sell | 9,753 | $9.55 | $93,173.33 | -4.9% | |
| Jan 2, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 22,127 | $9.58 | $211,889.21 | -3.0% | |
| Jan 2, 2020 | Rosenberg Ellen65 | Chief Legal Officer | Sell | 10,448 | $9.56 | $99,883.92 | -4.9% | |
| Dec 16, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $9.55 | $191,014.00 | -2.6% | |
| Dec 2, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $10.38 | $207,618.00 | -2.6% | |
| Nov 25, 2019 | Crowley John F67 | Chairman &CEO | Sale+OE | 40,000 | $10.01 | $400,204.00 | -5.2% |